SCHEMBL11218264

SCHEMBL11218264

CC(C(O)c1cccs1)N(C)C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.50
KDM4E B2RXH2 2/20 0.50
ALOX5 P09917 1/20 0.45
CYP3A4 P08684 3/20 0.44
CYP2D6 P10635 3/20 0.44
SLC6A2 P23975 3/20 0.44
SLC6A4 P31645 3/20 0.44
SLC6A3 Q01959 3/20 0.44
KCNH2 Q12809 3/20 0.44
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
KEAP1 Q14145 1/20 0.41
TSHR P16473 2/20 0.38
MAPT P10636 3/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
CNR2 P34972 1/20 0.36
AOC3 Q16853 1/20 0.35
PKM P14618 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20604377 0.79 ALOX5 (0.46) ALDH1A1ALOX5CYP3A4CYP2D6SLC6A2
SCHEMBL2608973 0.79 ALOX5 (0.46) ALDH1A1ALOX5CYP3A4CYP2D6SLC6A2
SCHEMBL19757663 0.79 ALOX5 (0.46) ALDH1A1ALOX5CYP3A4CYP2D6SLC6A2
SCHEMBL19757658 0.79 ALOX5 (0.46) ALDH1A1ALOX5CYP3A4CYP2D6SLC6A2
SCHEMBL20604375 0.79 ALOX5 (0.46) ALDH1A1ALOX5CYP3A4CYP2D6SLC6A2
SCHEMBL31556325 0.79 CES2 (0.52) ALDH1A1KDM4EALOX5CYP3A4CYP2D6
SCHEMBL1535361 0.77 ALOX5 (0.45) ALDH1A1KDM4EALOX5CYP3A4CYP2D6
SCHEMBL28472127 0.77 SLC6A2 (0.55) ALDH1A1ALOX5CYP3A4CYP2D6SLC6A2
SCHEMBL21031031 0.76 CYP3A4 (0.43) ALDH1A1ALOX5CYP3A4CYP2D6SLC6A2
SCHEMBL21030387 0.76 CYP3A4 (0.43) ALDH1A1ALOX5CYP3A4CYP2D6SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101407510-A Preparation of duloxetine hydrochloride intermediate ZHEJIANG HUAHAI PHARM CO LTD (CN) 2009-04-15 CN claimed
CN-1300137-C Method for preparing (S)-(+)-N,N-dimethyl-3-(1-naphthoxy)-3-(2-thienyl) propylamine SHANGHAI PHARMACEUTICAL INDUST (CN) 2007-02-14 CN claimed
CN-1676522-A Method for preparing (S)-(+)-N,N-dimethyl-3-(1-naphthoxy)-3-(2-thienyl) propylamine SHANGHAI PHARMACEUTICAL INDUST (CN) 2005-10-05 CN claimed
CN-1067681-C Asymmetric synthesis LILLY CO ELI (US) 2001-06-27 CN claimed
CN-1109470-A Asymmetric synthesis LILLY CO ELI (US) 1995-10-04 CN claimed
JP-57095961-A None JP disclosed
CN-101407510-A Preparation of duloxetine hydrochloride intermediate ZHEJIANG HUAHAI PHARM CO LTD (CN) 2009-04-15 CN disclosed
CN-101389621-A Method for preparing (S) - (-) -N, N-dimethyl-3- (2-thienyl) -3-hydroxypropyl amine serving as intermediate of duloxetine TEVA PHARMA (IL) 2009-03-18 CN disclosed
CN-1300137-C Method for preparing (S)-(+)-N,N-dimethyl-3-(1-naphthoxy)-3-(2-thienyl) propylamine SHANGHAI PHARMACEUTICAL INDUST (CN) 2007-02-14 CN disclosed
CN-1676522-A Method for preparing (S)-(+)-N,N-dimethyl-3-(1-naphthoxy)-3-(2-thienyl) propylamine SHANGHAI PHARMACEUTICAL INDUST (CN) 2005-10-05 CN disclosed
JP-S5795961-A ERYTHRO-2-AMINO-1-HETEROCYCLIC PROPANOL DERIVATIVE AND ITS PREPARATION GRELAN PHARMACEUT CO LTD 1982-06-15 JP disclosed